S&P lowers Huntington Memorial Hospital’s rating to ‘A-‘

S&P Global Ratings lowered the rating on Pasadena, Calif.-based Huntington Memorial Hospital’s $232 million of series 2005, 2014A and 2014B bonds to “A-” from “A.”

Advertisement

“The downgrade reflects persistently high operating losses, which exceed budgeted expectations and have in turn resulted in thin debt service coverage for the rating level,” said S&P analyst Cynthia Keller.

The outlook is stable, reflecting S&P’s view of HMH’s strong business position and solid balance sheet.

More articles on healthcare finance:
Experts share 3 tips for improving RCM
RCM tip of the day: Understand the utilization of technology
CPC generates $58M in Medicare savings in 2015

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.